FDA Advisory No.2023-0765 || Engagement with Consultancy Firms to Transact Business with the Food and Drug Administration
The FDA is aware that there are several companies or individuals offering services related to FDA regulations such as assisting with product approvals or providing advice on regulatory compliance. However, […]
FDA Advisory No.2023-0518 || Operating Periods of FDA Online Services
The Food and Drug Administration (FDA) is currently undergoing system maintenance and upgrade. We understand that this may cause inconvenience, but this upgrade is necessary to improve the efficiency and […]
FDA Advisory No.2023-0407-A || Hindi Awtorisadong Paggamit ng DOH at FDA Logo sa Pagrerekomenda ng Produktong Pangkalusugan
Naipaabot sa kaalaman ng aming ahensya ang “Public Health Recommendation” na nakalagay sa isang social media platform na nagsasaad na inirerekomenda ng FDA ang naturang produktong pangkalusugan. Nais paalalahanan ang […]
FDA Advisory No.2023-0407 || Unauthorized use of the DOH and FDA Logo in the Recommendation of a Health Product
Our office received a report that a certain “Public Health Recommendation” with an unauthorized use of the Department of Health (DOH) and the Food and Drug Administration (FDA) logo was […]
FDA Advisory No.2023-0312 || External Communications for the Food and Drug Administration
Due to the influx of communications and transactions with improper designation and erroneous address, the Food and Drug Administration Action Center (FDAC) has been encountering delays in the processing of […]
FDA Advisory No.2023-0258 || Implementation of the Pharmaceutical Inspection Cooperation Scheme (PIC/S) Guide for Good Manufacturing Practice (GMP) for Medicinal Products in Compliance with DOH Administrative Order No. 2012-0008
This is in compliance with Administrative Order No. 2012-0008 (AO 2012-0008), or the rules on “Adoption and Implementation of the Pharmaceutical Inspection Cooperation Scheme (PIC/S) Guide for Good Manufacturing Practice […]
FDA Advisory No.2023-0165 || INTEGRATION OF LANDBANK LINK.BIZPORTAL TO THE FDA ESERVICES PORTAL
The Food and Drug Administration (FDA), in its commitment to provide effective and efficient public health service delivery, has integrated the Landbank Link.BizPortal Online Payment Gateway System to the FDA […]
FDA Advisory No.2022-1621 || Health Guidelines and Precautions for Meeting Requests with the Office of the Director General
In response to the continuing threat of the COVID-19 pandemic, the following guidelines are to be complied with by all non-FDA personnel who wish to arrange for a meeting with […]
FDA Advisory No.2022-1535 || WARNING AGAINST THE FALSIFICATION/ TAMPERING OF CASH DEPOSIT SLIP AND OTHER RELATED DOCUMENTS SUBMITTED TO THE FDA
The Food and Drug Administration (FDA) – FDA Academy has recently become aware of acts involving tampered/altered/falsified Cash Deposit Slips submitted by participant stakeholders as proof of payment for training/s […]
FDA Advisory No.2022-1291-A || Hindi Awtorisado at Lantarang Pag-Gamit ng FDA Advisory Template sa Pag-Rekomenda ng Produktong Pangkalusugan
Naiparating sa aming ahensya ang pag-gamit ng isang food supplement ng opisyal na template na inilalabas tuwing may FDA Advisory, at pinalitan ito ng “FDA Recommendation” na nagsasabing ang kanilang […]